Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Absci (ABSI) Research & Development (2020 - 2025)

Absci's Research & Development history spans 6 years, with the latest figure at $19.2 million for Q3 2025.

  • For Q3 2025, Research & Development rose 7.03% year-over-year to $19.2 million; the TTM value through Sep 2025 reached $74.4 million, up 28.91%, while the annual FY2024 figure was $63.9 million, 32.85% up from the prior year.
  • Research & Development for Q3 2025 was $19.2 million at Absci, down from $20.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $20.5 million in Q2 2025 and bottomed at $7.0 million in Q1 2021.
  • The 5-year median for Research & Development is $15.3 million (2024), against an average of $14.3 million.
  • The largest annual shift saw Research & Development surged 390.23% in 2021 before it fell 28.96% in 2023.
  • A 5-year view of Research & Development shows it stood at $15.8 million in 2021, then dropped by 28.23% to $11.3 million in 2022, then increased by 8.43% to $12.3 million in 2023, then surged by 49.78% to $18.4 million in 2024, then rose by 4.75% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for ABSI's Research & Development are $19.2 million (Q3 2025), $20.5 million (Q2 2025), and $16.4 million (Q1 2025).